Temporal Variation of the Exposure to Pesticides in the Employees of the Limoges University Hospital (VESTAL)

January 16, 2025 updated by: University Hospital, Limoges
In a sample of 300 employees of the Limoges University Hospital, it is proposed to explore the intraindividual and interindividual variability of urinary concentrations of glyphosate and 320 other pesticides. The employees will fill a questionary in which will allow to explore the relationships between the concentrations, lifestyle and dietary habits.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The general population is exposed to pesticides through the ingestion of food and water. The presence of pesticides in human urine has been demonstrated in numerous studies. Conventionally, biological monitoring studies use an undifferentiated urine sample or the first morning urine. The reliability of measuring a single-point urinary concentration to represent the profile of pesticide exposure in individuals over time is, however, questionable. Rare studies reporting intra-individual outcomes of pesticide exposure have been conducted in specific populations, such as children and pregnant women.

It is proposed to carry out a descriptive biomonitoring study of the urinary concentration of approximately 320 pesticides in a sample of the general population. Among these, the study will focus on glyphosate.

The originality of our study is:

  • (i) Exploration of exposure to the main pesticides in a sample of 300 people by measuring urinary concentration by specific and sensitive methods of LC-MS/MS and GC-MS/MS; These 300 subjects will be hospital staff of the Limoges University Hospital.
  • (ii) Exploration of the intra-individual variability of exposure by repeating measurements in urine samples taken over a 24-hour period and/or several times over the course of a week;
  • (iii) Determination of the frequency of subjects who have potentially been exposed to doses higher than the acceptable daily intake (in particular for glyphosate) (iv) The association of these exposure values with data from a self-administered questionnaire in order to identify the determinants of this exposure
  • (V) Estimating the predictability/reliability of a single urine sample to represent this exposure of individuals/populations over time.

Study Type

Interventional

Enrollment (Actual)

300

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Limoges, France, 87042
        • CHU de Limoges

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Adult 18 years and over.
  • Employed by the University Hospital of Limoges.
  • Having consented to participate in the study after being informed.

Exclusion Criteria:

- Adult with a professional activity during which he is required to handle or come into contact with glyphosate

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Pesticide measurement

Among the 300 people recruited:

  • 300 will each provide 3 urine samples collected on 3 different days during a week (e.g. Monday, Wednesday and Friday)
  • 50 will each provide 3 urine samples collected at sunrise, in the middle and then at the end of the day over a period of 24 hours, on 3 different days during a week (e.g. Monday, Wednesday and Friday).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
glyphosate overconsumption
Time Frame: 1 week
Proportion of individuals with an estimated daily consumption of glyphosate greater than the acceptable daily intake of glyphosate
1 week

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Identification of determinant of exposure to glyphosate
Time Frame: 1 week
Proportion of individuals with a daily consumption of glyphosate greater than the acceptable daily intake according to socio-demographic determinants(age, sex, profession and socio-professional category)
1 week
Identification of determinant of exposure to glyphosate
Time Frame: 1 week
Proportion of individuals with a daily consumption of glyphosate greater than the acceptable daily intake according to lifestyles (city center, peri-urban, rural )
1 week
Identification of determinant of exposure to glyphosate
Time Frame: 1 week
Proportion of individuals with a daily consumption of glyphosate greater than the acceptable daily intake according to proximity to agricultural activities
1 week
Identification of determinant of exposure to glyphosate
Time Frame: 1 week
Proportion of individuals with a daily consumption of glyphosate greater than the acceptable daily intake according to use of glyphosate at home
1 week
Identification of determinant of exposure to glyphosate
Time Frame: 1 week
Proportion of individuals with a daily consumption of glyphosate greater than the acceptable daily intake according to dietary habits
1 week
Coefficient of variation of the glyphosate concentrations
Time Frame: 1 week
Calculation of the coefficient of variation of the glyphosate concentrations measured 3 times over a period of 24 hours
1 week
Intra-individual variability of urinary glyphosate concentrations
Time Frame: 1 week
Comparison of the average GLP concentrations measured on 3 occasions (at sunrise, in the middle then at the end of the day) over a period of 24 hours.
1 week
Impact of urine sample collection schedule on glyphosate concentration measurement
Time Frame: 1 week
According to the methodology proposed by Wang et al. : a linear mixed-effects model to determine which measure produces the best estimate of exposure; itself obtained by calculating the mean of the observed values.
1 week
Identification of determinants of exposure to a panel of around 320 pesticides
Time Frame: 1 week
Proportion of subjects with a detectable concentration among the 320 pesticides measured by specific LC-MS and GC-MS methods and prevalence of individuals with a detectable concentration according to socio-demographic determinants
1 week
Identification of determinants of exposure to a panel of around 320 pesticides
Time Frame: 1 week
Proportion of subjects with a detectable concentration among the 320 pesticides measured by specific LC-MS and GC-MS methods and prevalence of individuals with a detectable concentration according to lifestyles
1 week
Identification of determinants of exposure to a panel of around 320 pesticides
Time Frame: 1 week
Proportion of subjects with a detectable concentration among the 320 pesticides measured by specific LC-MS and GC-MS methods and prevalence of individuals with a detectable concentration according to proximity to agricultural activities
1 week
Identification of determinants of exposure to a panel of around 320 pesticides
Time Frame: 1 week
Proportion of subjects with a detectable concentration among the 320 pesticides measured by specific LC-MS and GC-MS methods and prevalence of individuals with a detectable concentration according to use of glyphosate at home
1 week
Identification of determinants of exposure to a panel of around 320 pesticides
Time Frame: 1 week
Proportion of subjects with a detectable concentration among the 320 pesticides measured by specific LC-MS and GC-MS methods and prevalence of individuals with a detectable concentration according to dietary habits
1 week
Intra-individual variability of urinary 320 pesticides concentrations
Time Frame: 1 week
Calculation of the coefficient of variation of the concentrations of each of the pesticides (expressed in µg/L or µg/g of creatinine) measured 3 times (at sunrise, in the middle and then at the end of the day) over a period of 24 hours
1 week
Impact of urine sample collection schedule on 320 pesticides concentration measurement
Time Frame: 1 week
Comparison of the average concentrations of each of the pesticides measured on 3 occasions (at sunrise, in the middle and then at the end of the day) over a period of 24 hours. According to the methodology proposed by Wang et al.: a linear mixed-effects model to determine which measure produces the best estimate of exposure; itself obtained by calculating the mean of the observed values.
1 week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 17, 2023

Primary Completion (Actual)

August 2, 2024

Study Completion (Actual)

August 2, 2024

Study Registration Dates

First Submitted

September 13, 2023

First Submitted That Met QC Criteria

September 19, 2023

First Posted (Actual)

September 21, 2023

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

January 16, 2025

Last Verified

January 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 87RI23_0014 (VESTAL)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Toxicology

Clinical Trials on Urine sampling

Subscribe